{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:57Z","timestamp":1786997997854,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.waojou.2024.100928","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:15:42Z","timestamp":1721888142000},"page":"100928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-1487","authenticated-orcid":false,"given":"Marco","family":"Caminati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Federica","family":"Carpagnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amaddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bixio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Caldart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"De Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Del Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Festi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Friso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Frulloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Krampera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Micheletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Schiappoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tenero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2024.100928_bib1","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.57187\/s.3644","article-title":"Healthcare access and health equity: intricate challenges for rare diseases","volume":"153","author":"Wehrli","year":"2023","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.waojou.2024.100928_bib2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2022.01.043","article-title":"Controversies in allergy: the potential role of biologics as first-line therapy in eosinophilic disorders","volume":"10","author":"Dellon","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100928_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2018.02.031","article-title":"The eosinophil: for better or worse, in sickness and in health","volume":"121","author":"Bochner","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib4","first-page":"36","article-title":"Biologics for eosinophilic granulomatosis with polyangiitis","volume":"23","author":"Caminati","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-023-00904-6","article-title":"Barrier dysfunction in eosinophilic esophagitis","author":"McGowan","year":"2023","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.waojou.2024.100928_bib6","article-title":"Basophil blood cell count is associated with enhanced factor II plasma coagulant activity and increased risk of mortality in patients with stable coronary artery disease: not only neutrophils as prognostic marker in ischemic heart disease","volume":"10","author":"Pizzolo","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.waojou.2024.100928_bib7","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1038\/s41598-021-85852-9","article-title":"Venous thrombosis and predictors of relapse in eosinophil-related diseases","volume":"11","author":"R\u00e9au","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.waojou.2024.100928_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100676","article-title":"Current and emerging biologic therapies targeting eosinophilic disorders","volume":"15","author":"Pitlick","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2024.100928_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100809","article-title":"Hypereosinophilic syndromes - an enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment","volume":"49","author":"Helbig","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.waojou.2024.100928_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/hematology.2022000367","article-title":"Approach to the patient with suspected hypereosinophilic syndrome","volume":"2022","author":"Klion","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.waojou.2024.100928_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100928_bib12","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2022.03.034","article-title":"Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review","volume":"10","author":"Requena","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100928_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/heartjnl-2020-317202","article-title":"Hypereosinophilic syndrome: considerations for the cardiologist","volume":"108","author":"Bondue","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.waojou.2024.100928_bib14","first-page":"222","article-title":"The portrait of a stranger: the hypereosinophilic syndrome with cardiac involvement","volume":"61","author":"Iv\u0103nescu","year":"2023","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.waojou.2024.100928_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s43044-023-00418-6","article-title":"Hypereosinophilic vasculitis with Raynaud phenomenon presentation: a case report","volume":"75","author":"Phuong","year":"2023","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.waojou.2024.100928_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.chest.2020.09.247","article-title":"Approach to eosinophilia presenting with pulmonary symptoms","volume":"159","author":"Rosenberg","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.waojou.2024.100928_bib17","article-title":"Extracorporeal membrane oxygenation for refractory acute eosinophilic pneumonia","volume":"79","author":"Bay","year":"2023","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.waojou.2024.100928_bib18","article-title":"Pericardial effusion and progressive bilateral effusion as rare presentations of idiopathic hypereosinophilic syndrome","volume":"15","author":"Soma","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.waojou.2024.100928_bib19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.waojou.2024.100928_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4168\/aair.2023.15.5.580","article-title":"Real-world investigation of eosinophilic-associated disease overlap (REVEAL): analysis of a US claims database","volume":"15","author":"Brailean","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.waojou.2024.100928_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.anai.2023.02.022","article-title":"Hypereosinophilic syndrome in Europe: retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization","volume":"130","author":"Hwee","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib22","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.jaip.2020.04.025","article-title":"Single-organ and multisystem hypereosinophilic syndrome patients with gastrointestinal manifestations share common characteristics","volume":"8","author":"Kuang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2024.100928_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0031-1299176","article-title":"Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding","volume":"229","author":"Balaskas","year":"2012","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.waojou.2024.100928_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2014.01.018","article-title":"Eosinophilic myositis: an updated review","volume":"13","author":"Selva-O'Callaghan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.waojou.2024.100928_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jns.2014.10.023","article-title":"Central nervous system involvement of hypereosinophilic syndrome: a report of 10 cases and a literature review","volume":"347","author":"Lee","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.waojou.2024.100928_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10157-020-02012-5","article-title":"Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome","volume":"25","author":"Dong","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.waojou.2024.100928_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0277-4","article-title":"Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm","volume":"9","author":"Leru","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2024.100928_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13023-023-02696-4","article-title":"French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes","volume":"18","author":"Groh","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.waojou.2024.100928_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.waojou.2024.100928_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.autrev.2016.11.001","article-title":"Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?","volume":"16","author":"Lef\u00e8vre","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.waojou.2024.100928_bib31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaci.2023.03.011","article-title":"Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis","volume":"151","author":"Wechsler","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.rmed.2010.09.011","article-title":"Lung involvement in hypereosinophilic syndromes","volume":"105","author":"Dulohery","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.waojou.2024.100928_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108982","article-title":"What we have learned about lymphocytic variant hypereosinophilic syndrome: a systematic literature review","volume":"237","author":"Shi","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/his.15021","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: a workshop report with focus on novel entities and a literature review including paediatric cases","volume":"83","author":"Saft","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.waojou.2024.100928_bib35","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jaip.2021.01.030","article-title":"CD3-CD4+ lymphocytic variant hypereosinophilic syndrome: diagnostic tools revisited","volume":"9","author":"Carpentier","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100928_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2019.151412","article-title":"Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: a reference laboratory experience","volume":"44","author":"Shi","year":"2020","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.waojou.2024.100928_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ajcp\/aqaa056","article-title":"Contemporary classification and diagnostic evaluation of hypereosinophilia","volume":"154","author":"Mattis","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.waojou.2024.100928_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/asheducation-2018.1.326","article-title":"Hypereosinophilic syndrome: approach to treatment in the era of precision medicine","volume":"2018","author":"Klion","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.waojou.2024.100928_bib39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib40","unstructured":"Nucala European public assessment report \u2013 epar, available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/nucala. Last accessed 25 th November 2023."},{"issue":"4","key":"10.1016\/j.waojou.2024.100928_bib41","first-page":"549","article-title":"Biologics for the treatments of allergic conditions: severe asthma","volume":"40","author":"Caminati","year":"2020","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.waojou.2024.100928_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13023-023-02918-9","article-title":"Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance","volume":"18","author":"Caminati","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.waojou.2024.100928_bib43","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.jaip.2023.07.026","article-title":"Biologics and hypereosinophilic syndromes: knowledge gaps\u00a0and controversies","volume":"11","author":"Kuang","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.100928_bib44","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.clinthera.2021.05.014","article-title":"Justification of the subcutaneous mepolizumab dose of 300 mg in eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome","volume":"43","author":"Pouliquen","year":"2021","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.waojou.2024.100928_bib45","unstructured":"NCT04191304, available at: www.clincaltrials.gov. Last accessed 25 th November 2023."},{"key":"10.1016\/j.waojou.2024.100928_bib46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2024.100928_bib47","unstructured":"NCT05334368, available at: www.clincaltrials.gov. Last accessed 25 th November 2023."},{"key":"10.1016\/j.waojou.2024.100928_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clml.2012.09.018","article-title":"Long-term follow-up of patients with hypereosinophilic syndrome treated with alemtuzumab, an anti-CD52 antibody","volume":"13","author":"Strati","year":"2013","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.waojou.2024.100928_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2004.05206.x","article-title":"Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report","volume":"127","author":"Pitini","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.waojou.2024.100928_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2009.01.069","article-title":"Treatment of FIP1L1\/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody","volume":"123","author":"Wagner","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jdcr.2020.02.030","article-title":"Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment","volume":"6","author":"Wieser","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.waojou.2024.100928_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of\u00a0myeloproliferative hypereosinophilic syndrome in the\u00a0United States and an estimate of all hypereosinophilic\u00a0syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100928_bib53","unstructured":"Azienda Ospedaliera Universitaria Integrata Verona\/Verona Integrated University Hospital, Protocollo Direttore Sanitario\/Strategic Direction Protocol 41721, 01.07.2022, available at: www.aovr.veneto.it."},{"key":"10.1016\/j.waojou.2024.100928_bib54","unstructured":"Azienda Ospedaliera Universitaria Integrata Verona\/Verona Integrated University Hospital, Protocollo\/Protocol 34434 - Delibera di Istituzione\/Deliberation of Multidisciplinary Group Institution, 08.06.2023, available at: www.aovr.veneto.it."},{"key":"10.1016\/j.waojou.2024.100928_bib55","unstructured":"Azienda Ospedaliera Universitaria Integrata Verona\/Verona Integrated University Hospital, Deliberazione del Direttore Generale\/Deliberation of the General Director nr. 751, 21\/07\/2023, Modello organizzativo presa in carico malattie rare aoui verona \u201crare-diseases clinic center\u201d\/Organizational model for the management of rare disease at Verona Integrated University Hospital \u201crare-diseases clinic center\u201d, available at: www.aovr.veneto.it."}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T20:09:22Z","timestamp":1724530162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1939455124000590"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100928","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100928"}}